A 20% drop in pps is expected when short term speculators buy a stock hoping for a quick buck on pending news. Only 192 million out of 25 billion shares traded hands does equal a sell off. Hopefully the new buyers will hold like the rest of us as the company continues to make progress despite covid-19, shortages of chips and delays by new partners to execute as a result. Management continues to be optimistic and supportive of progress. Back in March, I posted I looked forward to second quarter earnings and I thought third and fourth quarters would be the real growth quarters as roll out of new products by all at that time four distribution partners would have inventory and momentum introducing the products to those needing pain management as an alternative to addictive opioids. I think now that the speculative traders have moved on pps will bounce back and we shall continue the march towards profitability as developments are reported. Second quarter to me shows that in a very short time we are on our way.